LBP AM’s Eli Lilly LLY Stock Holding History

LBP AM’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$172M	Sell	186,999 -37,167	-17%	-$37.7M	2.35%	7
2025 Q4	$241M	Buy	224,166 +9,107	+4%	+$8.71M	2.79%	6
2025 Q3	$164M	Buy	215,059 +21,875	+11%	+$16.3M	2.02%	8
2025 Q2	$151M	Buy	193,184 +81,928	+74%	+$63.7M	2.12%	9
2025 Q1	$91.9M	Sell	111,256 -22,723	-17%	-$18.9M	1.42%	13
2024 Q4	$103M	Buy	133,979 +30,555	+30%	+$25.3M	1.4%	13
2024 Q3	$91.6M	Buy	103,424 +60,876	+143%	+$54.7M	1.38%	13
2024 Q2	$38.5M	Buy	42,548 +264	+0.6%	+$211K	1.58%	9
2024 Q1	$32.9M	Sell	42,284 -6,631	-14%	-$4.72M	1.31%	12
2023 Q4	$28.5M	Sell	48,915 -9,213	-16%	-$5.38M	0.63%	39
2023 Q3	$31.2M	Buy	58,128 +7,959	+16%	+$4.1M	0.69%	38
2023 Q2	$23.5M	Buy	50,169 +9,990	+25%	+$4.19M	0.56%	54
2023 Q1	$13.8M	Sell	40,179 -2,210	-5%	-$745K	0.35%	77
2022 Q4	$15.5M	Buy	+42,389	New	+$15M	0.44%	61

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

LBP AM's LLY Position: Q1 2026 in Review

LBP AM reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $37.7M and leaving 186,999 shares worth $172M. The position accounts for 2.35% of the portfolio, ranked #7.

LBP AM first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $241M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

LBP AM held 186,999 shares of Eli Lilly worth $172M as of Q1 2026.
LBP AM sold 37,167 Eli Lilly shares in Q1 2026, an estimated $37.7M.
Eli Lilly made up 2.35% of LBP AM's portfolio in Q1 2026, its #7 holding.
LBP AM first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
LBP AM's Eli Lilly position peaked at $241M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.